	Ranbaxy whistleblower reveals how he exposed massive pharmaceutical fraud
	AstraZeneca heals patent rift with Ranbaxy - Financial Times
	Ranbaxy's Reign of Error Continues as FDA Flunks Its New York Drug Factory
	Ranbaxy: The Pitfalls of Generic Drug Dependence - Forbes
	Ranbaxy agrees to release records to prosecutors - nj.com
	Ranbaxy's war over generic Lipitor - May. 4, 2011 - CNN Business
	Generic Lipitor lots recalled due to glass particles; Ranbaxy yanks 40 lots of the cholesterol drug - New York Daily News
	Ranbaxy pleads guilty, to pay $500 million in U.S. settlement